4.8 Review

Upconversion-based photodynamic cancer therapy

Journal

COORDINATION CHEMISTRY REVIEWS
Volume 379, Issue -, Pages 82-98

Publisher

ELSEVIER SCIENCE SA
DOI: 10.1016/j.ccr.2017.09.006

Keywords

Photodynamic therapy; Upconversion nanoparticles; Photosensitizers; UCNP-based PDT; Synergistic therapy

Funding

  1. National Natural Science Foundation of China [51725202, 51372260, 51702211]
  2. Shanghai Excellent Academic Leaders Program [16XD1404000]

Ask authors/readers for more resources

Photodynamic therapy (PDT) has become widely accepted and utilized for tumor therapy. Considering the natural shortcomings (e.g., lack of an ideal photosensitizer and limited light penetration depth), lanthanide doped upconversion nanoparticles (Ln-doped UCNP), which can be excited with near-infrared light (NIR) for UV/visible/NIR upconversion luminescence (UCL) emissions, show great potential for augmenting biological treatment with PDT for solid tumors and for visual bioimaging of disease lesions. This review summarizes the basic concepts and important influence factors on PDT, the optimized construction of UCNP-based photosensitizer (UCNP-PS) systems, and some representative examples of UCNP-based PDT (UCPDT) applications in combination with other traditional therapy methods, such as chemotherapy, radiotherapy, photothermal therapy (PIT) and gene therapy. This review will provide guidance for the design and fabrication of future new UCNP-based nanocomposites for synergistic UC-PDT therapy. (C) 2017 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available